Teleflex Celebrates 400,000 Patients Treated With the Minimally Invasive UroLift® System
Retrieved on:
Thursday, December 15, 2022
Prostate, Hematuria, BPH, Bleeding, Quality of life, Annual report, Emergency medicine, NYSE, Health, Security (finance), Radiology, Heat, Anesthesia, Urology, American Urological Association, National Association Medical Staff Services, TFX, Pelvic pain, European Association of Urology, Infection, System 1, Teleflex, Patient, Medical imaging, Dysuria
“At Teleflex, we are honored to play an important role in enhancing the quality of life of hundreds of thousands of men with BPH.”
Key Points:
- “At Teleflex, we are honored to play an important role in enhancing the quality of life of hundreds of thousands of men with BPH.”
The UroLift® System is a minimally invasive treatment for lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). - More than 400,000 men have been treated with the UroLift® System in select markets worldwide.1
Learn more at UroLift.com . - Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives.
- We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers.